These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 20015030)

  • 1. Development of nanoparticles for antimicrobial drug delivery.
    Zhang L; Pornpattananangku D; Hu CM; Huang CM
    Curr Med Chem; 2010; 17(6):585-94. PubMed ID: 20015030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology solutions to restore antibiotic activity.
    Shimanovich U; Gedanken A
    J Mater Chem B; 2016 Feb; 4(5):824-833. PubMed ID: 32263154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of emerging trends in the treatment of tuberculosis.
    Kaur M; Garg T; Narang RK
    Artif Cells Nanomed Biotechnol; 2016; 44(2):478-84. PubMed ID: 25365354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management.
    Simoes S; Carvalheiro M; Gaspar MM
    Curr Pharm Des; 2016; 22(43):6577-6586. PubMed ID: 27396598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.
    Cheng Y; Wang J; Rao T; He X; Xu T
    Front Biosci; 2008 Jan; 13():1447-71. PubMed ID: 17981642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.
    Xie S; Tao Y; Pan Y; Qu W; Cheng G; Huang L; Chen D; Wang X; Liu Z; Yuan Z
    J Control Release; 2014 Aug; 187():101-17. PubMed ID: 24878179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructures as promising tools for delivery of antimicrobial peptides.
    Brandelli A
    Mini Rev Med Chem; 2012 Jul; 12(8):731-41. PubMed ID: 22512554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci.
    Ahangari A; Salouti M; Heidari Z; Kazemizadeh AR; Safari AA
    Drug Deliv; 2013; 20(1):34-9. PubMed ID: 23311651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic nanoparticles for antimicrobial drug delivery.
    Azhar SL; Lotfipour F
    Pharmazie; 2012 Oct; 67(10):817-21. PubMed ID: 23136713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.
    Lakshminarayanan R; Ye E; Young DJ; Li Z; Loh XJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1701400. PubMed ID: 29717819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active targeted drug delivery for microbes using nano-carriers.
    Lin YS; Lee MY; Yang CH; Huang KS
    Curr Top Med Chem; 2015; 15(15):1525-31. PubMed ID: 25877093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
    Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
    Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sol-gel encapsulation of binary Zn(II) compounds in silica nanoparticles. Structure-activity correlations in hybrid materials targeting Zn(II) antibacterial use.
    Halevas E; Nday CM; Kaprara E; Psycharis V; Raptopoulou CP; Jackson GE; Litsardakis G; Salifoglou A
    J Inorg Biochem; 2015 Oct; 151():150-63. PubMed ID: 26198972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the synthesis and application of nanoparticles for drug delivery.
    Park W; Na K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(4):494-508. PubMed ID: 25583540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes.
    Rudramurthy GR; Swamy MK; Sinniah UR; Ghasemzadeh A
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27355939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
    González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state on the development of nanoparticles for use against bacterial gastrointestinal pathogens. Focus on chitosan nanoparticles loaded with phenolic compounds.
    Madureira AR; Pereira A; Pintado M
    Carbohydr Polym; 2015 Oct; 130():429-39. PubMed ID: 26076644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.